The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

Use of clonazepam in mania and schizoaffective disorders

Published Online:https://doi.org/10.1176/ajp.141.9.1111

The authors report three cases in which clonazepam controlled the acute symptoms in one manic and two schizoaffective patients. Clonazepam treatment led to a decrease in agitation and logorrhea, without the side effects associated with neuroleptics.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.